A detailed history of Arkadios Wealth Advisors transactions in Novo Nordisk A S stock. As of the latest transaction made, Arkadios Wealth Advisors holds 18,762 shares of NVO stock, worth $1.97 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
18,762
Previous 19,045 1.49%
Holding current value
$1.97 Million
Previous $2.72 Million 17.84%
% of portfolio
0.14%
Previous 0.19%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$119.07 - $145.42 $33,696 - $41,153
-283 Reduced 1.49%
18,762 $2.23 Million
Q2 2024

Jul 29, 2024

BUY
$122.71 - $146.91 $635,392 - $760,699
5,178 Added 37.34%
19,045 $2.72 Million
Q1 2024

Apr 30, 2024

BUY
$102.11 - $135.92 $328,998 - $437,934
3,222 Added 30.27%
13,867 $1.78 Million
Q4 2023

Jan 24, 2024

BUY
$87.78 - $105.45 $612,177 - $735,408
6,974 Added 189.98%
10,645 $1.1 Million
Q3 2023

Oct 13, 2023

BUY
$90.94 - $199.54 $166,511 - $365,357
1,831 Added 99.51%
3,671 $333,000
Q2 2023

Jul 26, 2023

SELL
$155.98 - $172.65 $21,525 - $23,825
-138 Reduced 6.98%
1,840 $297,000
Q1 2023

May 02, 2023

BUY
$132.34 - $159.14 $32,952 - $39,625
249 Added 14.4%
1,978 $314,000
Q4 2022

Jan 11, 2023

BUY
$102.55 - $135.33 $177,308 - $233,985
1,729 New
1,729 $0
Q4 2021

Feb 03, 2022

SELL
$95.88 - $117.08 $12,847 - $15,688
-134 Closed
0 $0
Q3 2021

Oct 19, 2021

SELL
$84.42 - $106.62 $2,026 - $2,558
-24 Reduced 15.19%
134 $12,000
Q2 2021

Jul 28, 2021

BUY
$67.66 - $84.76 $8,660 - $10,849
128 Added 426.67%
158 $13,000
Q1 2021

Apr 26, 2021

SELL
$67.06 - $75.82 $11,668 - $13,192
-174 Reduced 85.29%
30 $2,000
Q4 2020

Feb 09, 2021

BUY
$63.89 - $73.8 $13,033 - $15,055
204 New
204 $14,000
Q2 2020

Aug 10, 2020

SELL
$58.54 - $67.94 $5,971 - $6,929
-102 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$49.46 - $64.78 $5,044 - $6,607
102 New
102 $6.14 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Arkadios Wealth Advisors Portfolio

Follow Arkadios Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Arkadios Wealth Advisors with notifications on news.